PPBT files Form 6-K on Nasdaq minimum bid price update
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
Purple Biotech Ltd. (PPBT) furnished a Form 6-K reporting that on October 20, 2025 it issued a press release titled “Purple Biotech Announces Receipt of Nasdaq Regarding Minimum Bid Price Notification.”
The press release is included as Exhibit 99.1. This filing serves as a notice to investors about the company’s receipt of a Nasdaq minimum bid price notification and provides the related disclosure via the attached exhibit.
Positive
- None.
Negative
- None.
FAQ
What did Purple Biotech (PPBT) file?
Purple Biotech filed a Form 6-K.
What is the subject of the PPBT 6-K?
It reports a press release about a Nasdaq minimum bid price notification.
When was the press release issued by PPBT?
The press release was issued on October 20, 2025.
What is included as an exhibit in this filing?
Exhibit 99.1 contains the press release titled “Purple Biotech Announces Receipt of Nasdaq Minimum Bid Price Notification.”
What is Purple Biotech’s ticker symbol?
Purple Biotech trades under the symbol PPBT.